BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34244538)

  • 1. Serum urate and cardiovascular events in the DCCT/EDIC study.
    Jenkins AJ; Braffett BH; Basu A; Bebu I; Dagogo-Jack S; Orchard TJ; Wallia A; Lopes-Virella MF; Garvey WT; Lachin JM; Lyons TJ;
    Sci Rep; 2021 Jul; 11(1):14182. PubMed ID: 34244538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes: The DCCT/EDIC Trials.
    Budoff M; Backlund JC; Bluemke DA; Polak J; Bebu I; Schade D; Strowig S; Raskin P; Lachin JM;
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 2):1341-1349. PubMed ID: 30878435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC.
    Jaffa MA; Bebu I; Luttrell D; Braffett BH; Lachin JM; Hunt K; Lopes-Virella M; Luttrell L; Lyons TJ; Jaffa AA;
    Diabetes; 2020 Nov; 69(11):2440-2445. PubMed ID: 32826295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
    Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Schade D; Braffett B; Kosiborod M; Lopes-Virella M; Soliman EZ; Herman WH; Bluemke DA; Wallia A; Orchard T; Lachin JM;
    Diabetes Care; 2020 Apr; 43(4):867-874. PubMed ID: 32001614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Keshavarzi S; Gao X; Braffett BH; Canty AJ; Herman WH; Orchard TJ; Dagogo-Jack S; Nathan DM; Lachin JM; Paterson AD;
    Diabetes Care; 2021 Jun; 44(6):1309-1316. PubMed ID: 33883194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study.
    Bebu I; Braffett BH; Pop-Busui R; Orchard TJ; Nathan DM; Lachin JM;
    Diabetologia; 2017 Oct; 60(10):2084-2091. PubMed ID: 28711972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT/EDIC study.
    Bebu I; Braffett BH; Orchard TJ; Lorenzi GM; Nathan DM; Herman WH; Lachin JM
    Diabetes Res Clin Pract; 2021 Jan; 171():108591. PubMed ID: 33310124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ; Zinman B; Brunzell JD;
    Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
    Özalp Kızılay D; Şen S; Ersoy B
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.
    Gubitosi-Klug R; Gao X; Pop-Busui R; de Boer IH; White N; Aiello LP; Miller R; Palmer J; Tamborlane W; Wallia A; Kosiborod M; Lachin JM; Bebu I;
    Diabetes Care; 2021 Jul; 44(7):1499-1505. PubMed ID: 33980605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study.
    Keshavarzi S; Braffett BH; Pop-Busui R; Orchard TJ; Soliman EZ; Lorenzi GM; Barnie A; Karger AB; Gubitosi-Klug RA; Dagogo-Jack S; Paterson AD;
    Diabetes Care; 2021 May; 44(5):1125-1132. PubMed ID: 33632724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin A1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: The CACTI Study.
    Horton WB; Snell-Bergeon JK
    J Clin Endocrinol Metab; 2023 Jun; 108(7):e444-e449. PubMed ID: 36637994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Purnell JQ; Braffett BH; Zinman B; Gubitosi-Klug RA; Sivitz W; Bantle JP; Ziegler G; Cleary PA; Brunzell JD;
    Diabetes Care; 2017 Dec; 40(12):1756-1762. PubMed ID: 29138273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.
    Sousa GR; Pober D; Galderisi A; Lv H; Yu L; Pereira AC; Doria A; Kosiborod M; Lipes MA
    Circulation; 2019 Feb; 139(6):730-743. PubMed ID: 30586738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypouricemia and Mortality Risk in the US General Population.
    D'Silva KM; Yokose C; Lu N; McCormick N; Lee H; Zhang Y; Choi HK
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1171-1179. PubMed ID: 33026684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid and diabetes: Is there a link?
    Katsiki N; Papanas N; Fonseca VA; Maltezos E; Mikhailidis DP
    Curr Pharm Des; 2013; 19(27):4930-7. PubMed ID: 23278493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malmö Preventive Project cohort in southern Sweden.
    Kapetanovic MC; Nilsson P; Turesson C; Englund M; Dalbeth N; Jacobsson L
    Arthritis Res Ther; 2018 Aug; 20(1):190. PubMed ID: 30157929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.